NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (Germany: J90) ("NurExone" or the "Company"), a biopharmaceutical company developing exosome-based ...

A June 2024 real-world study of NXTSTIM’s FDA-approved AI wearable nerve stimulation device found that 92% of patients ...

Newswatch 16's Kerry Kearns talked to a neurosurgeon at UPMC about the connection between the brain and spinal cord and when ...

Spinal muscular atrophy (SMA) is a disorder affecting the motor neurons—nerve cells that control voluntary muscle movement. These cells are located in the spinal cord. Because the muscles cannot ...

Department of Medical Imaging, Shanxi Key Laboratory of Intelligent Imaging and Nanomedicine, First Hospital of Shanxi Medical University, Taiyuan 030001, P. R. China Laboratory Animal Center, Shanxi ...

Realizing a Phase I human clinical trial commencing to test the efficacy and safety of the transplantation of olfactory cell nerve bridges to treat chronic spinal cord injury. Since the passing of ...

Auto news: Surprising reason councils use these black road cables. © 2024 Nine Entertainment Co.

getting customers to stop cutting the cord. The largest US cable-TV provider is planning a major marketing push next year to promote more than 10 streaming services that it will offer at no ...

Cells for the transplantation will be harvested from the patient’s own nose, purified, and prepared into specialised nerve bridges which are then transplanted into the injury site within the spinal ...

“Our innovative nerve bridges, combined with the high purity olfactory cells, offer what we think is the best hope for treating spinal cord injury,” Professor James St John of Griffith ...